Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2005
05/19/2005US20050107386 Methods of treating diseases and disorders by targeting multiple kinases
05/19/2005US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC
05/19/2005US20050107382 e.g. 2-(4-fluoro-2-methylphenyl)-5-(5-methoxymethyl-4-(6-methoxypyridin-3-yl)-4H-[1,2,4]triazol-3-yl)-pyridine; treatment of arousal disorder, orgasmic disorder, sexual pain disorder and premature ejaculation, preterm labor, appetite and feeding disorders, dysmenorrhoea, congestive heart failure, etc.
05/19/2005US20050107374 Hydroxybenzimidazole pyrimidines or pyridines, as for example 4-(2-((2,6-dimethylphenyl)oxy)-1H-benzimidazol-1-yl)-N-(4-(4-methyl-1-piperazinyl)phenyl)-2-pyrimidinamine; for treatment of protein tyrosine kinase-associated disorders such as immunologic disorders
05/19/2005US20050107370 Pyrrole derivatives as antimycobacterial compounds
05/19/2005US20050107365 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics
05/19/2005US20050107362 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
05/19/2005US20050107355 Agonists of the kappa opioid receptor for treating gastrointestinal disorders, pain, and pruritus; N-{2-[(S)-3-hydroxy-pyrrolidin-1-yl]-(S)-1-phenyl-ethyl}-N-methyl-2-phenylamino-acetamide
05/19/2005US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease
05/19/2005US20050106709 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna)
05/19/2005US20050106106 In-vivo diagnostic method by near infrared radiation
05/19/2005DE10348044A1 Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen Dual-alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/19/2005CA2544678A1 Modulators of cellular adhesion
05/19/2005CA2543602A1 Triazole compounds and uses related thereto
05/19/2005CA2543199A1 Use of crth2 antagonist compounds in therapy
05/19/2005CA2540704A1 Benzoimidazole compounds
05/18/2005EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
05/18/2005EP1530566A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
05/18/2005EP1263724B1 Novel compounds
05/18/2005EP1098885B9 Imidazole compounds and their use as adenosine deaminase inhibitors
05/18/2005CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament
05/18/2005CN1617858A Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (igf-1)
05/18/2005CN1617855A Inhibitors of cytosolic phospholipase A2
05/18/2005CN1617744A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
05/18/2005CN1616425A Noval benzoindoline compounds, their preparing method and pharmaceutical composition containing them
05/18/2005CN1202095C Heteroaromatic ring compounds
05/18/2005CN1202087C Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
05/18/2005CN1202081C Amidino and guanidino bita-azetidinone tryptase inhibitors
05/18/2005CN1201821C Stable complex of insoluble chemical compound
05/17/2005US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus
05/17/2005US6894070 Herbicides
05/17/2005US6894057 Administering to the living body a oxo-azabicyclo derivative to treat disease selected from arthritis, osteoporosis, periodontal diseases, inflammatory bowel disease, psoriasis, multiple sclerosis, asthma, cancer and macular degeneration
05/17/2005US6894054 Central nervous system disorders; muscular disorders
05/17/2005US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives
05/17/2005US6894047 Triazine compounds useful as sorbitol dehydrogenase inhibitors
05/17/2005US6894046 For treating eosinophil-dependent inflammatory diseases, asthma
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005US6893471 For dyeing human hair
05/17/2005CA2301967C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2301543C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2252907C Novel 2,3 disubstituted-4(3h)-quinazolinones
05/17/2005CA2125549C Tetrazole derivatives, their production and use
05/12/2005WO2005042520A1 Benzimidazolyl derivatives
05/12/2005WO2005042519A1 Pyrimidines as inhibitors of phosphoinositide -3-kinases (pi3k)
05/12/2005WO2005042518A2 Substituted heterocyclic compounds and methods of use
05/12/2005WO2005042516A2 Ligands of melanocortin receptors and compositions and methods related thereto
05/12/2005WO2005042502A1 Amide derivatives
05/12/2005WO2005042501A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
05/12/2005WO2005042497A2 Benzimidazoles useful as modulators of ion channels
05/12/2005WO2005042496A1 (benzimidazol-2-yl)-phenyl-benzyl-amine derivatives and methods for inhibiting heparanase activity
05/12/2005WO2005042489A1 N-substituted benzene sulfonamides
05/12/2005WO2005042444A2 Platinum complex and luminescent element
05/12/2005WO2005041888A2 Pyrimidin-4-one compounds, compositions and methods
05/12/2005WO2005041867A2 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3’(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline
05/12/2005WO2005041858A2 Mucin production inhibitor
05/12/2005WO2005030131A3 Bis-quinazoline compounds for the treatment of bacterial infections
05/12/2005WO2005023765A8 Method for catalyzing amidation reactions by the presence of co2
05/12/2005WO2005018644B1 Capped pyrazinoylguanidine sodium channel blockers
05/12/2005WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
05/12/2005WO2005014539A3 Pyrrole-based hmg-coa reductase inhibitors
05/12/2005WO2005003100A3 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
05/12/2005WO2005003099A3 Pyrimidines useful as modulators of voltage-gated ion channels
05/12/2005WO2004093829A8 (-)1-(4-sulfamylaryl)-3-substituted-5-heteroaryl-2 pyrazolines as inhibitors of cyclooxygenase-2
05/12/2005US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate
05/12/2005US20050101657 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative
05/12/2005US20050101651 Viricides; protease inbhibitors; useful for inhibiting the activity of picornaviral 3C proteases; for example, 6-carbamoyl-4S-{2S-[(5-naphthalen-1-yl-1H-pyrrole-2-carbonyl)-amino-3-phenyl-propionylamino}-hex-2(trans)-enoic acid ethyl ester
05/12/2005US20050101650 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005US20050101617 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
05/12/2005US20050101614 Heterocyclic GABAA subtype selective receptor modulators
05/12/2005US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
05/12/2005US20050101609 Quinazoline derivatives as kinase inhibitors
05/12/2005US20050101590 Cannabinoid receptor agonists
05/12/2005US20050101588 7-Amino alkylidenyl-heterocyclic quinolones and naphthyridones
05/12/2005US20050101586 Novel 5-HT2A receptor ligands
05/12/2005US20050101567 Using a sulfonamide containing compound
05/12/2005CA2544350A1 N-substituted benzene sulfonamides
05/12/2005CA2543942A1 Indirubin-type compounds, compositions, and methods for their use
05/12/2005CA2543918A1 Benzimidazoles useful as modulators of ion channels
05/12/2005CA2543710A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
05/12/2005CA2543608A1 Pyrimidines as inhibitors of phosphoinositide -3-kinases (pi3k)
05/12/2005CA2543346A1 Benzimidazolyl derivatives
05/12/2005CA2543216A1 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline
05/12/2005CA2542995A1 Substituted heterocyclic compounds and methods of use
05/11/2005EP1529778A1 Production method of pyrimidine derivative, intermediate therefor
05/11/2005EP1529530A1 Compounds affecting glucokinase
05/11/2005EP1529044A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
05/11/2005EP1529042A1 Arylamides
05/11/2005EP1529034A1 Benzoylpyrazolones substituted by 3-aminocarbonyl
05/11/2005EP1470114A4 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones
05/11/2005EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
05/11/2005EP1066269B1 Trisubstituted 1,3,5-triazine derivatives for treatment of hiv infections
05/11/2005CN1615300A Benzimidazole derivatives and their use as GNRH antagonists
05/11/2005CN1613857A Dipyrromethene metal chelate compounds
05/11/2005CN1613852A Cesium triazoleamide compounds and their preparation and use
05/11/2005CN1200932C Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
05/10/2005US6891044 Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use
05/10/2005US6891041 Reacting phthalidyl-3-triphenylphosphonium salt with 4-pyridine aldehyde in the presence of a basic adjuvant, then reacting with hydrazine hydrate and acid treatment; avoids environmental and safety problems
05/10/2005US6890938 Antiinflammatory agents
05/10/2005US6890935 Pharmaceutical compositions and methods for use
1 ... 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 ... 626